MYOHTII
Live / Applied — Fourth extension granted (statement of use) (as of 28 Oct 2025)
What this means for you
Not registered yet, but its 31 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97774696
- Mark type
- Stylized text
- Filed
- 31 Jan 2023
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
Owner
- Scholar Rock, Inc., Cambridge, MA, US
- Scholar Rock, Inc., Cambridge, MA, US
Prosecution history
- 29 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Oct 2025 — SOU EXTENSION 4 GRANTED
- 28 Oct 2025 — SOU EXTENSION 4 FILED
- 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 3 GRANTED
- 25 Apr 2025 — SOU EXTENSION 3 FILED
- 25 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2024 — SOU EXTENSION 2 GRANTED
- 25 Oct 2024 — SOU EXTENSION 2 FILED
- 25 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Mar 2024 — SOU EXTENSION 1 GRANTED
- 08 Mar 2024 — SOU EXTENSION 1 FILED